Based on current data, the evidence for efficacy of available anti-IgE and anti-IL-5 antibodies on the market is very low, and more studies are needed in order to recommend their use in the treatment of CRSwNP patients [75]. The gene discussed is IL5; the disease is chronic rhinosinusitis with nasal polyps.